Iron Isomaltoside/Ferric Derisomaltose vs Iron Sucrose for Treatment of Iron Deficiency Anemia in Non-Dialysis-Dependent Chronic Kidney Disease

NCT02940860 PHASE3 COMPLETED Results posted

Evaluation of safety and efficacy of iron isomaltoside/ferric derisomaltose compared with iron sucrose, in subjects with both non-dialysis-dependent chronic kidney disease (NDD-CKD) and iron deficiency anaemia (IDA).

Details

Lead sponsor	Pharmacosmos A/S
Phase	PHASE3
Status	COMPLETED
Enrolment	1538
Start date	Tue Nov 29 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Tue May 29 2018 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Iron Deficiency Anaemia
• Iron Deficiency Anemia
• Chronic Kidney Disease

Interventions

• Iron isomaltoside/ferric derisomaltose
• Iron sucrose

Countries

United States